BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6608935)

  • 21. Gastrointestinal involvement in the Sézary syndrome.
    Cohen MI; Widerlite LW; Schechter GP; Jaffe E; Fischmann AB; Schein PS; Macdonald JS
    Gastroenterology; 1977 Jul; 73(1):145-9. PubMed ID: 140832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphometric study of lymphoid cells in mycosis fungoides and its simulators.
    Sinha AK; Singh MK; Dinda AK; Ramam M
    Indian J Pathol Microbiol; 2003 Jan; 46(1):28-33. PubMed ID: 15027714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogold detection of CD3 and CD4 antigens in patients with Mycosis fungoides.
    Grzanka AA; Placek W; Grzanka A
    Neoplasma; 2006; 53(5):424-7. PubMed ID: 17013537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral photochemotherapy in lichen planus (LP) and mycosis fungoides (MF): ultrastructural modifications of the infiltrating cells.
    Ortonne JP; Schmitt D; Alario A; Thivolet J
    Acta Derm Venereol; 1979; 59(3):211-8. PubMed ID: 87077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ultrastructural study of a case of mycosis fungoides].
    Bonneau H; Cesarini JP
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(5):612-7. PubMed ID: 4871274
    [No Abstract]   [Full Text] [Related]  

  • 28. The application of the metalophil method for the demonstration of histiocytes.
    Van Unnik JA
    J Pathol; 1984 Dec; 144(4):233-9. PubMed ID: 6084054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural characteristics of the interdigitating dendritic cell in dermatopathic lymphadenopathy of mycosis fungoides patients.
    Poblete MT; Figueroa CD; Caorsi I
    J Pathol; 1987 Apr; 151(4):263-9. PubMed ID: 3035155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A comparative study of the quantitative distribution and ultrastructure of Langerhans cells in the epidermis of patients with chronic benign dermatoses and mycosis fungoides].
    Tukhvatullina ZG; Akovbian VA; Khoroshaev VA; Persina IS
    Arkh Patol; 1991; 53(5):24-8. PubMed ID: 1831968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ultrastructural examination of a blistering lesion of mycosis fungoides bullosa.
    Ueda C; Makino T; Asano Y; Watanabe H; Hanakawa H; Shimizu T
    Br J Dermatol; 2011 Jul; 165(1):213-4. PubMed ID: 21428969
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of electron microscopy in mycosis fungoides and other cutaneous oncologic conditions.
    Schwartz RA; Bangert JL
    Ariz Med; 1979 May; 36(5):344-7. PubMed ID: 454202
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular structure and function in normal and neoplastic lymphoid cells.
    Zucker-Franklin D
    Arch Intern Med; 1975 Jan; 135(1):55-60. PubMed ID: 163073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The ultrastructural characteristics of the early diagnosis of mycosis fungoides].
    Buianova OV
    Lik Sprava; 2000; (5):60-1. PubMed ID: 11031453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies.
    Rowden G; Phillips TM; Lewis MG; Wilkinson RD
    J Cutan Pathol; 1979 Oct; 6(5):364-82. PubMed ID: 316438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.
    Requena L; González-Guerra E; Angulo J; DeVore AE; Sangueza OP
    Br J Dermatol; 2008 Jan; 158(1):157-62. PubMed ID: 17999702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell membrane characteristics of "mycosis cells" in the skin and lymph node.
    van Leeuwen AW; Meijer CJ; de Man JC
    J Invest Dermatol; 1975 Oct; 65(4):367-9. PubMed ID: 1080784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.